A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual ...

The business may not be as strong as its performance this year suggests.

Artificial intelligence (AI) isn't the only industry with explosive growth potential.

Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of biotechs chipping away at 2025’s iced-over IPO market. | Immunology biotech ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, ...

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

State officials on Monday have announced renovation plans at SUNY Upstate Medical Center’s CNY Biotech Accelerator as well as nearly $3 million in funding to help advance the ...

FAR Biotech, a computational drug discovery company, has officially relocated to Wisconsin. The move marks a significant ...